Ayala Pharmaceuticals Inc (ADXS)

[khaled_shatila]

what would be good is that if they also follow this quickly with a licensing deal for AXAL even if not with much upfront money as long as we don't incur any additional financial burden that would keep the science moving forward for free. I've always thought that ADXS NEO is really where the money is but there can still be value in the other programs. Also i read last week about Keytruda combo for renal cell cancer with 73% improvement in survival and they were calling these results "unprecedented" i believe that was presented in a conference over the weekend. ADXS has lots of potential current management just needs to navigate the financial difficulties carefully (from current shareholder perspective) as from a company perspective they can dilute and reverse to keep this thing alive as long as they need to.
Good luck